This heartburn drug linked to higher risk of pancreatic cancer

Credit: CC0 Public Domain

A Michigan Medicine gastroenterologist discusses the recent recall of ranitidine, or Zantac, and shares treatment options and tips for individuals living with heartburn.

Recently, the Food and Drug Administration requested a manufacturer’s market withdrawal of ranitidine, or Zantac, which many individuals take to treat heartburn.

This recall means that all ranitidine products have been removed from the market and will no longer be available for new or existing prescriptions or over-the-counter use.

The FDA found that the drug may contain a contaminant known as N-nitrosodimethylamine, or NDMA, that is associated with pancreatic cancer, posing risks to patients.

Michigan Medicine’s William Chey, M.D., a gastroenterologist and professor of medicine and nutrition sciences, is an expert when it comes to treating heartburn.

In this video, he discusses the recent ranitidine recall and offers tips for treating the condition now that Zantac is no longer an option.

Written by JINA SAWANI.